Investigation of inhibitory effect of Cucurbitacin i and Ecballium elaterium L. extract on breast cancer cells
2016
0 views
0 downloads
Advisor: Prof. Dr. İsmet Yılmaz
Abstract (EN)
Cancer is among the major health problems nowadays. Breast cancer has a significant mortality, especially in women. Although important progress has been made in cancer therapy, it is not enough to decrease mortality rate. Thus, the patients search alternative therapy methods. One of the most popular is herbal remedies. Objective of this study was to investigate the inhibitory effect of Cucurbitacin I and Ecballium elaterium L. (fruit juice and chloroform extract) on breast cancer cells. Cucurbitacin I content of E.elaterium fruit juice and chloroform extract was quantified using HPLC. The cytotoxic effects of the fruit juice, chloroform extract and Cucurbitacin I on breast cancer cells were determined by MTT, wound healing and colony formation assay. According to MTT results, it is observed that a significant inhibitory effect in Cucurbitacin I treated breast cancer cell lines MCF-7 and MDA-MB-231 with %68,76 and % 82,48 at 400 nM for 72 h, respectively. Inhibitory effect of the fruit juice of E. elaterium was %85,16 for MCF-7 cells and %52,47 for MDA-MB-231 at 10 mg/mL for 72 h. In addition, chloroform extract inhibited %87,51 of MCF-7 cells and %64,95 of MDA-MB-231 cells at 0,1 mg/mL for 72 h. In the dose-time Wound Healing assay, it sees that while cell migration continued in control group (untreated) at 36 h, there was significantly decrease in the cell migration in treated cells with Cucurbitacin I, E. elaterium fruit juice and chloroform extract. It was also found that treated cells with Cucurbitacin I, E. elaterium fruit juice and chloroform extract are unable to form colonies after specific dose in Colony Formation assay. Our data showed that Cucurbitacin I, E.elaterium fruit juice and chloroform extract have anti-proliferative activity on the breast cancer cells. Clarifying the mechanisms of cucurbitacins enable to identify new molecular targets for breast cancer therapy. Key Words: Cucurbitacin I, Breast Cancer, Ecballium elaterium
Author
Dr. Kadir Yılmaz
How to Cite
Kadir Yılmaz (Doctorate thesis). Investigation of inhibitory effect of Cucurbitacin i and Ecballium elaterium L. extract on breast cancer cells, 2016, İnönü University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from İnönü University
- Knowledge, opinions and applications of pediatric nurses towards therapeutic games(2017)
- The effects of systemic pistacia eurycarpa yalt administration on alveolar bone loss and oxidative stress in rats with experimental periodontitis(2021)
- The effect of motivational interviews for primiparous pregnant women with low normal birth belief on medical and natural birth belief(2022)
- Retrospective investigation of genetic etiology in pediatric epilepsy patients based on targeted next generation sequence analysis datas(2022)
- The commentary methodology in the commentary on al-Fath al-Mubyn bi-Sharh al-Arba'eyn by Ibn Hajar al-Haytamy(2022)
- Comparison of serum BDNF, S100B levels of patients with bipolar disorder in manic and remission periods with healthy volunteers and evaluation of results with neuropsychological tests(2022)
